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ABSTRACT 20 
Study question: Is periconceptional maternal one-carbon (I-C) metabolism associated 21 
with embryonic morphological development in non-malformed ongoing pregnancies? 22 
Summary answer: Serum vitamin B12, red blood cell (RBC) folate and plasma total 23 
homocysteine (tHcy) are associated with embryonic development according to the 24 
Carnegie stages.  25 
What is known already: Derangements in maternal I-C metabolism affect reproductive 26 
and pregnancy outcomes, as well as future health of the offspring.  27 
Study design, size, duration: Between 2010 and 2014, women with singleton ongoing 28 
pregnancies were enrolled in a prospective periconceptional cohort study. 29 
Participants/materials, setting, methods: 234 pregnancies, including 138 spontaneous 30 
pregnancies with strict pregnancy dating and 96 pregnancies derived from in vitro 31 
fertilization (IVF), intracytoplasmatic sperm injection (ICSI) or cryo-embryo transfer 32 
(IVF/ICSI pregnancies), underwent longitudinal transvaginal three-dimensional 33 
ultrasound (3D US) scans from 6+0 up to 10+2 weeks of gestation. Carnegie stages were 34 
defined using internal and external morphologic criteria in a virtual reality system. 35 
Maternal venous blood samples were collected at enrolment for serum vitamin B12, RBC 36 
folate and plasma total homocysteine (tHcy) assessment. Associations between 37 
biomarker concentrations and longitudinal Carnegie stages were investigated using linear 38 
mixed models.  39 
Main results and the role of chance: We performed a median of three 3D US scans per 40 
pregnancy (range 1-5) resulting in 600 good quality datasets for the Carnegie stage 41 
annotation (80.5%). Vitamin B12 was positively associated with embryonic development 42 
in the total study population (β=0.001 (95% CI: 0.000; 0.002), p<0.05) and in the subgroup 43 
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of strictly dated spontaneous pregnancies (β=0.002 (95% CI: 0.001; 0.003), p<0.05). Low 44 
vitamin B12 concentrations (-2 standard deviation (SD), 73.4 pmol/l) are associated with 45 
delayed embryonic development by 1.4 days (95% CI: 1.3-1.4) compared to high 46 
concentrations (+2SD, 563.1 pmol/l). RBC folate was positively associated with Carnegie 47 
stages only in IVF/ICSI pregnancies (β=0.001 (95% CI: 0.0005; 0.0015), p<0.05). Low 48 
RBC folate concentrations (-2SD, 875.4 nmol/l) were associated with a 1.8-day delay 49 
(95% CI: 1.7-1.8) in development compared to high concentrations (+2SD, 2119.9 50 
nmol/l). tHcy was negatively associated with embryonic development in the total study 51 
population (β = -0.08 (95% CI:  -0.14; -0.02), p<0.01), as well as in the IVF/ICSI subgroup 52 
(β= -0.08 (95% CI: -0.15; -0.01), p<0.05). High tHcy concentrations (+2SD, 10.4 µmol/l) 53 
were associated with a delay of 1.6 days (95% CI: 1.5-1.7) in embryonic development 54 
compared to low concentrations (-2 SD, 3.0 µmol/l).  55 
Limitations, reasons for caution: The study was performed in a tertiary care centre, 56 
resulting in high rates of folic acid supplement use and comorbidity that may reduce the 57 
external validity of our findings. 58 
Wider implications of the findings: In periconceptional care, maternal I-C biomarkers 59 
should be taken into account as predictors of embryonic morphological development. 60 
Combining embryonic size measurements with morphological assessment could better 61 
define normal embryonic development. 62 
Study funding/competing interest(s): The work was funded by the Department of 63 
Obstetrics and Gynaecology, Erasmus MC, University Medical Centre, Rotterdam, The 64 
Netherlands. RPMST is CSO of the startup company Slimmere Zorg and CEO of eHealth 65 
Care Solutions. The authors declare no conflicts of interest. 66 
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Trial registration number: not applicable. 67 
Key words: Carnegie stage, maternal one-carbon metabolism, homocysteine, folate, 68 
vitamin B12.  69 
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INTRODUCTION 
One-carbon (I-C) metabolism is known to play a crucial role in cellular metabolism and 70 
proliferation, as well as in the regulation of gene expression through epigenetic 71 
mechanisms. Useful biomarkers of I-C metabolism for research and clinical practice are 72 
serum vitamin B12 and folate, red blood cell (RBC) folate and plasma total homocysteine 73 
(tHcy). Several studies linked maternal I-C biomarkers to reproductive, pregnancy and 74 
health outcomes in the offspring (Steegers-Theunissen et al., 2013; Kalhan, 2016; Bergen 75 
et al., 2012; Yajnik et al., 2014; van Uitert and Steegers-Theunissen, 2013a). Most 76 
evidence is available on the association between maternal folate deficiency, folic acid 77 
supplement use and congenital anomalies (Steegers-Theunissen et al., 2013). 78 
Nevertheless, plasma tHcy concentration seems to be a more sensitive marker, with 79 
increased concentrations strongly associated with miscarriage, hypertensive disorders, 80 
preterm birth and birth defects (Ronnenberg et al., 2007; Steegers-Theunissen et al., 81 
1991; Hogeveen et al., 2012; Vollset et al., 2000). Due to the increased adherence to a 82 
vegetarian diet and frequent association with vitamin deficiency, recent research also 83 
focused on the associations between vitamin B12, birth defects and birth weight 84 
(Finkelstein et al., 2015).  85 
The introduction of high resolution three-dimensional ultrasound (3D US) scans combined 86 
with visualization in immersive virtual reality (VR) systems, providing real depth 87 
perception and more sensitive embryonic size measurements and morphological 88 
evaluations, has markedly improved the opportunity to accurately study the 89 
periconceptional period (time window: 14 weeks pre-conception to 10 weeks post-90 
conception) (Rousian et al., 2010; Baken et al., 2014; Steegers-Theunissen et al., 2013). 91 
So far these innovative techniques were used to study embryonic crown-rump length 92 
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(CRL) and volume (EV) trajectories as non-invasive measures of first trimester embryonic 93 
growth (Steegers-Theunissen et al., 2016). On the other hand, the Carnegie stages of 94 
human embryonic development were introduced as a century old morphological 95 
classification of fixated embryos dividing the embryonic period (58 post-conceptional 96 
days) into 23 stages (O’Rahilly et al., 1987). The combination of 3D US and VR 97 
visualization will allow us to investigate embryonic morphological development in vivo, 98 
according to the longitudinal annotation of the Carnegie stages (O’Rahilly and Müller, 99 
2010; Blaas et al., 1998; Verwoerd-Dikkeboom et al., 2008). Despite the fact that the 100 
normal sequence of developmental events is constant and predictable in every embryo, 101 
different times and velocities can occur, making comparisons possible and worthwhile.  102 
Here, we aim to investigate the associations between periconceptional maternal 103 
biomarkers of I-C metabolism and first trimester embryonic development, using serial 104 
Carnegie stage annotation obtained by 3D US and VR.  105 
MATERIALS AND METHODS 106 
This study was performed in the setting of the Rotterdam Periconception Cohort (Predict 107 
Study), a prospective periconceptional tertiary hospital-based cohort study started in 2009 108 
at the Department of Obstetrics and Gynaecology of the Erasmus MC, University Medical 109 
Centre, Rotterdam, with the aim to assess periconceptional determinants and predictors 110 
of pregnancy outcome and offspring health (Steegers-Theunissen et al., 2016).  111 
Study population and sample 112 
All women before 8+0 weeks of gestation who conceived spontaneously, or after 113 
intrauterine insemination (IUI), in vitro fertilization (IVF), intracytoplasmatic sperm 114 
injection (ICSI) or cryopreserved embryo transfer, were eligible for participation between 115 
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2010 and 2014 (figure 1). After exclusion for age below 18 years old, twins, miscarriage, 116 
ectopic implantation, intrauterine fetal death, congenital anomalies and oocyte(s) 117 
donation, 347 singleton ongoing pregnancies were enrolled. Since the Carnegie stages 118 
describe embryonic development until the end of the embryonic period (10+2 weeks, 58 119 
post-conceptional days), we excluded seven additional pregnancies for missing 3D US 120 
scans before 10+2 weeks of gestation. Among spontaneously conceived pregnancies, we 121 
selected pregnancies with known first day of last menstrual period (LMP), self-reported 122 
regular cycle and observed crown-rump length (CRL) measurement corresponding to the 123 
expected according to the Robinson curves (<7 days different) (Robinson and Fleming, 124 
1975). The resulting total study population counted 234 pregnancies, consisting of 138 125 
spontaneous or intrauterine insemination (IUI) pregnancies with strict pregnancy dating 126 
and 96 IVF/ICSI pregnancies. Gestational age was defined from LMP for spontaneous 127 
pregnancies (adjusted for duration of the menstrual cycle if <25 or >31 days), from LMP 128 
or insemination date plus 14 days for IUI pregnancies, from the day of oocyte retrieval 129 
plus 14 days for IVF/ICSI pregnancies, and from embryo transfer day plus 17 or 18 days 130 
in pregnancies derived from transfer of cryopreserved embryos. Therefore, the total study 131 
population included only pregnancies with strict and reliable dating by definition. Since a 132 
possible influence of conception mode cannot be excluded, we performed the analysis 133 
first in the total study population using conception mode as a confounder and we further 134 
stratified the analysis to the two subgroups of strictly dated spontaneous and IVF/ICSI 135 
pregnancies.  136 
General data 137 
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Self-administered general questionnaires reporting items on age, geographical origin, 138 
education, obstetric and medical history, and periconceptional lifestyle (smoking, alcohol 139 
consumption, folic acid and multivitamin supplement use) were collected at enrolment. 140 
Anthropometric measures were recorded by trained researchers.  141 
Blood sample analysis  142 
One first trimester fasting venous blood sample for serum vitamin B12, RBC folate and 143 
plasma tHcy assessment was collected at enrolment and drawn in a vacutainer 144 
ethylenediamine tetraacetate (EDTA) tube and in a dry vacutainer tube (BD diagnostics, 145 
Plymouth, UK). The dry vacutainer tubes were centrifuged at 2,000 xg, serum was 146 
collected and analyzed for vitamin B12 measurement using an immunoelectro-147 
chemoluminescence assay (E170; Roche Diagnostics GmbH, Mannheim, Germany). 148 
Plasma was separated by centrifugation within one hour for determination of tHcy by 149 
using a sensitive liquid chromatography tandem mass spectrum method (HPLC-Tandem 150 
MS, Waters Micromass Quattro Premier XE Mass Spectrometer with Acquity UPLC 151 
system, Milford, Massachusetts, United States). EDTA-blood was kept on ice and 0.1 ml 152 
EDTA blood was hemolysed with 0.9 ml freshly prepared 1.0% ascorbic acid. The 153 
hematocrit was determined with the ADVIA 120 Hematology Analyzer (Bayer Diagnostics, 154 
Leverkusen, Germany). RBC folate was calculated with the following formula: (nM 155 
hemolysate folate × 10/hematocrit) - [nM serum folate × (1- hematocrit) /hematocrit] = nM 156 
RBC folate. 157 
Ultrasound data 158 
From 6+0 up to 10+2 weeks of gestation, all included women underwent serial 3D US scans 159 
performed by trained researchers using the high frequency (4.5 – 11.9 MHz) vaginal 160 
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probe of a GE Voluson E8 (GE Healthcare, Zipf, Austria). Ultrasound scans were 161 
performed on a weekly basis until 2013 and then reduced to a two weekly-basis after the 162 
pilot study showed an accurate modelling of growth trajectory obtained with 3 scans per 163 
pregnancy (at 7, 9, 11 weeks of gestation) (van Uitert et al., 2013b). The obtained 3D 164 
datasets were stored as Cartesian volumes and transferred to the BARCO I-Space VR 165 
system at the Department of Bioinformatics, Erasmus University Medical Centre, 166 
Rotterdam. This system, running the V-Scope volume rendering application, aims to 167 
improve dataset visualization by projecting a hologram in a 4-walled CAVE-like (Cave 168 
Automatic Virtual Environment) VR system, allowing full depth perception and intuitive 169 
interaction with the volume (Verwoerd-Dikkeboom et al., 2010; Koning et al., 2009). The 170 
Carnegie criteria for external and internal morphological characteristics were used by one 171 
trained researcher to stage all embryos, as previously described (Verwoerd-Dikkeboom 172 
et al., 2008; O’Rahilly and Müller, 2010). As external morphological characteristics we 173 
used the Carnegie criteria for the development of limbs (arms and legs) and embryonic 174 
curvature. Internal morphological characteristics primarily included the criteria for the 175 
brain cavity development. The assessment of Carnegie stages required 1 to 2 minutes 176 
per embryo.  177 
Statistical analysis 178 
In order to evaluate selection bias, we compared maternal baseline characteristics and 179 
biomarker concentrations between excluded and included pregnancies using Chi-square 180 
or exact tests for ordinal variables and Mann-Whitney U test for continuous variables. 181 
Univariable linear regression was performed to evaluate associations between maternal 182 
baseline characteristics and biomarker concentrations. 183 
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To estimate associations between maternal biomarkers of I-C metabolism and embryonic 184 
development, we treated the Carnegie stages as a continuous variable that was censored 185 
at its maximum value of 23. This was used as the response variable in separate linear 186 
mixed models estimated for the total study population and secondly for the subgroups of 187 
strictly dated spontaneous and IVF/ICSI pregnancies. This analysis allows the linear 188 
modelling of longitudinal measurements, taking into account the existing correlation 189 
between serial measurements within the same pregnancy and potential confounders for 190 
adjustment (parity, alcohol use, smoking, folic acid/multivitamin supplement use, fetal 191 
gender, maternal age, BMI and comorbidity). Firstly, we performed a crude analysis with 192 
adjustment for gestational age only (model 1) and secondly we adjusted for additional 193 
confounders (model 2). Finally, the estimates of embryonic developmental change 194 
expressed in days were determined comparing women with high (+2 standard deviation 195 
(SD)) and low (-2 SD) concentrations of the biomarkers that were significantly associated 196 
with the Carnegie stages in model 2. Due to the exclusion of pregnancies with uncertain 197 
dating and the possibility of selection bias, we additionally performed a sensitivity analysis 198 
including pregnancies with discordant CRL (n=15). P-values ≤0.05 were considered 199 
significant. All analyses were performed using IBM SPSS version 21.0 (Armonk, NY: IBM 200 
Corp) and R version 3.2.1 (The R Foundation for Statistical Computing). 201 
Ethical approval 202 
The protocol has been approved by the local medical ethics committee and all women 203 
signed a written informed consent before participation.  204 
RESULTS 205 
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We included 234 pregnancies with a median of three scans per pregnancy (range 1-5), 206 
counting for a total of 745 3D US scans. The Carnegie stage annotation was feasible in 207 
600 good quality datasets (success rate 80.5%). Carnegie stage distribution in the total 208 
study population ranged from stage 13 to 23 (6+0 – 10+2 weeks of gestation). Table I 209 
shows maternal characteristics and biomarker concentrations at baseline with 210 
comparisons between included and excluded ongoing pregnancies. The prevalence of 211 
hyperhomocysteinemia in the total study population was 1.3% (> 13 µmol/l). Vitamin B12 212 
was significantly associated with maternal age (β=0.15 pmol/l, (95%CI: 0.13; 0.16), 213 
p<0.05), RBC folate (β=0.20 pmol/l, (95% CI: 0.19; 0.20), p<0.01) and tHcy 214 
concentrations (β= -0.34 pmol/l, (95% CI: -0.37; -0.32), p<0.001). RBC folate was 215 
significantly associated with maternal age (β=0.20 nmol/l, (95% CI: 0.19; 0.21), p<0.01), 216 
smoking (β= -0.16 nmol/l, (95% CI: -0.25; -0.07), p<0.05), folic acid supplement use 217 
(β=0.23 nmol/l, (95% CI: 0.04; 0.43), p<0.001), comorbidity (β= -0.14 nmol/l, (95% CI: -218 
0.24; -0.04), p<0.05) and tHcy concentrations (β= -0.25 nmol/l, (95% CI: -0.27; -0.24), 219 
p<0.001).  220 
Embryonic development 221 
Embryonic development according to the Carnegie stages was comparable between the 222 
subgroups of strictly dated spontaneous and IVF/ICSI pregnancies (model 2, group effect: 223 
β= -0.20, (95% CI: -0.46; 0.05), p=0.12). Table II shows the estimates from linear mixed 224 
models. In model 2, vitamin B12 concentrations were positively associated with 225 
embryonic development in the total study population and in strictly dated spontaneous 226 
pregnancies, resulting in small, albeit significant estimates. In the total study population, 227 
low vitamin B12 concentrations (-2 SD, corresponding to 73.4 pmol/l) were associated 228 
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with a 1.4-day delay (95% CI: 1.3-1.4) in embryonic development compared to high 229 
concentrations (+2SD, corresponding to 563.1 pmol/l) (figure 2A). After full adjustment, 230 
RBC folate was positively associated with the Carnegie stages only in the IVF/ICSI 231 
subgroup, and low concentrations (-2SD, corresponding to 875.4 nmol/l) were associated 232 
with a 1.8-day delay (95% CI: 1.7-1.8) in embryonic development compared to high 233 
concentrations (+2SD, corresponding to 2119.9 nmol/l). Finally, tHcy was strongly and 234 
negatively associated with the Carnegie stages in the total study population and in the 235 
IVF/ICSI subgroup. In the total study population, high tHcy concentrations (+2SD, 236 
corresponding to 10.4 µmol/l) were associated with a 1.6-day delay (95% CI: 1.5-1.7) in 237 
embryonic development compared to low concentrations (-2SD, corresponding to 3.0 238 
µmol/l) (figure 2B). The sensitivity analysis including pregnancies with discordant CRL 239 
(n=15) did not modify the resulting associations (model 2, vitamin B12: β= 0.001, (95% 240 
CI: 0.0001 – 0.002), p=0.03; RBC folate: β= 0.000, (95% CI: -0.000 - 0.001), p=0.06; tHcy: 241 
β= -0.08, (95% CI: -0.15 - -0.02;), p=0.01). 242 
DISCUSSION 243 
This study shows significant associations between periconceptional maternal biomarkers 244 
of I-C metabolism and embryonic morphological development according to the Carnegie 245 
classification in ongoing non-malformed pregnancies. Moreover, IVF/ICSI conception did 246 
not affect embryonic morphological development compared to spontaneous conception 247 
in strictly dated pregnancies. The inclusion of pregnancies with discordant CRL revealed 248 
the same associations.  249 
Our results are in line with previous data showing associations between maternal I-C 250 
metabolism and several reproductive, pregnancy and health outcomes (Solé-Navais et 251 
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al., 2016; Yajnik and Deshmukh, 2012). Recently, maternal early pregnancy high tHcy 252 
(≥8.31 μmol/L) and low folate concentrations (≤9.10 nmol/L) have been negatively 253 
associated with fetal growth parameters, finally affecting birth weight (Bergen et al., 254 
2016). We also showed that an optimal periconceptional RBC folate level is associated 255 
with increased first trimester longitudinal CRL measurements compared to the lowest (β= 256 
0.24 √mm (95%CI: 0.04; 0.44), p=0.02) and highest quartile of concentrations (β= 0.29 257 
√mm (95%CI: 0.09; 0.49), p<0.01) (van Uitert et al., 2014). This result emphasizes that 258 
CRL accuracy in pregnancy dating is impacted by maternal I-C metabolism, as well as by 259 
several maternal characteristics and exposures (van Uitert et al., 2013b). Moreover, 260 
embryonic volume (EV) has been described as a more sensitive marker of first trimester 261 
growth restriction compared to CRL (Baken et al., 2013). We focused on the Carnegie 262 
stages as a century old classification that, together with embryonic size measurements, 263 
could implement first trimester investigation and better define a proper embryonic 264 
development. Since we excluded all pregnancies with congenital anomalies detected both 265 
in utero and after birth, our results indicate that even the developmental events of normal 266 
ongoing pregnancies are impacted by maternal I-C metabolism. This and previous 267 
findings indicate that first trimester growth and development are important embryonic 268 
outcomes affected by maternal environment. Nevertheless, CRL, EV and Carnegie 269 
stages also represent non-invasive reproducible markers with predictable associations 270 
with gestational age, leading to their potential use for pregnancy dating and raising the 271 
question which biomarker should be the best candidate (Robinson and Fleming, 1975; 272 
O'Rahilly and Müller, 2010). Due to the lack of an optimal pregnancy dating strategy and 273 
to unavoidable systematic errors related to the recall of the LMP, imprecise 274 
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ovulation/implantation dates and parental characteristics impacting embryonic ultrasound 275 
measurements, we defined gestational age based on a known LMP, regular cycle and 276 
concordant CRL. In this way, all ultrasound measurements could be read as response 277 
variables and outcome measurements. In order to reduce selection bias, we compared 278 
maternal baseline characteristics, showing that excluded women had a higher BMI, lower 279 
age and RBC folate concentrations. This may be mainly explained by the inclusion of a 280 
large population of subfertile women and pregnancies achieved after IVF/ICSI treatment 281 
(higher age, lower BMI, higher use of folic acid supplements). We also compared the 282 
subgroup of included and excluded spontaneous pregnancies showing indeed no 283 
significant results (data not shown). Moreover, the sensitivity analysis including 284 
pregnancies with discordant CRL confirmed the detected associations, reducing the 285 
possibility of selection bias.  286 
The mechanisms linking maternal I-C metabolism and embryonic development are not 287 
fully understood. Animal data showed that abnormal activations of I-C metabolism were 288 
associated with hypermethylation of mitochondrial DNA, mitochondrial malfunction and 289 
decreased oocyte quality (Jia et al., 2016). Recently, a suppression of the inflammatory 290 
and upregulation of the high-density lipoprotein pathways have been demonstrated in 291 
human follicular fluid of preconception folic acid supplement users (Twigt et al., 2015). 292 
Cellular apoptosis and protein homocysteinylation, both dependent on tHcy 293 
concentrations, have been suggested as contributors to neural tube, orofacial and cardiac 294 
defects (Jakubowski, 2006; Taparia et al., 2007). Finally, periconceptional I-C biomarker 295 
mediated epigenetic modifications could modify subsequent gene expression in the 296 
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embryo (Steegers-Theunissen et al., 2013). All these events may finally lead to impaired 297 
first trimester development, thereby supporting our results. 298 
Our findings also reveal that conception mode seems to modify the associations between 299 
blood biomarkers and Carnegie stages, despite the fact that no differences in embryonic 300 
development have been detected between the two subgroups. As expected, biomarker 301 
concentrations differed between spontaneous and IVF/ICSI pregnancies. Besides higher 302 
and longer preconceptional folic acid supplement use in the IVF/ICSI subgroup, also the 303 
ovarian stimulation treatment may affect I-C blood biomarker concentrations (Boxmeer et 304 
al., 2008). Moreover, the IVF/ICSI technique has been associated with different 305 
epigenetic patterns, gene expression and preimplantation embryo phenotype compared 306 
to spontaneous conception, possibly affecting embryonic responses to maternal I-C 307 
biomarkers and explaining different associations detected in our results (Kroener et al., 308 
2016; Zandstra et al., 2015; Giritharan et al., 2007; Song et al., 2015).  309 
The major strength of our study is the longitudinal evaluation of embryonic development  310 
using a median of three scans per patient, the use of 3D US with VR visualization and the 311 
consequent high success rate of the Carnegie stage assessment. This gives an accurate 312 
and precise picture of the course of first trimester development. Confounding by 313 
gestational age is minimized by including women with strict pregnancy dating only. The 314 
high rate of folic acid supplement use, resulting in an extremely low rate of 315 
hyperhomocysteinemia and high RBC folate concentrations, strongly underlines the 316 
importance of our results, since even clinically normal values of tHcy and a non-deranged 317 
I-C metabolism could impact embryonic development of non-malformed ongoing 318 
pregnancies. The most relevant limitation of this study is related to the tertiary care 319 
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setting, resulting in expected high rates of folic acid supplement use, chronic comorbidity 320 
and pregnancy complications. This may reduce the external validity of our findings. 321 
Despite it is reassuring that significant associations were confirmed in IVF/ICSI 322 
pregnancies where conception date is known by definition, the implantation date is not  323 
known and systematic errors in pregnancy dating are expected. Therefore, it is also 324 
possible that the small differences detected in embryonic development reflect an impact 325 
on the timing of implantation.  326 
Inadequacies in dietary B vitamins and lifestyle (i.e. smoke, alcohol and coffee 327 
consumption) have led to increased dangerous plasma tHcy concentrations in the last 328 
decades (Steegers-Theunissen et al., 2013). Our results suggest that this may negatively 329 
impact first trimester embryonic development resulting in the highest effect estimates in 330 
line with previous findings (Blanco et al., 2016; Steegers-Theunissen et al., 2013). Since 331 
plasma tHcy is an overall stable marker within the same individual and in uncomplicated 332 
pregnancies, a random periconceptional tHcy measurement is reflective of an individual's 333 
status and therefore could represent a potential useful predictor of embryonic 334 
development in a clinical setting (McKinley et al., 2001; López-Alarcón et al., 2015). 335 
Conversely, the small estimates detected for vitamin B12 and RBC folate may not 336 
address for their clinical use as embryonic development predictors. Nevertheless, while 337 
reduced CRL measurements have been associated with adverse pregnancy and health 338 
outcomes in the offspring (Mook-Kanamori et al., 2010; van Uitert et al., 2013c; Jaddoe 339 
et al., 2014), nothing is known about the clinical implications of first trimester 340 
developmental delay in ongoing pregnancies.  341 
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In conclusion, we have shown significant associations between periconceptional maternal 342 
biomarkers of I-C metabolism and Carnegie stages of embryonic development. Further 343 
research is needed to investigate associations between Carnegie stages and birth 344 
outcomes and to evaluate the validity of our results in the general population.  345 
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FIGURE LEGENDS 478 
Figure 1. Flow chart of the study population. IUFD: intrauterine fetal death, US: 479 
ultrasound, LMP: last menstrual period, CRL: crown-rump length, IUI: intrauterine 480 
insemination, IVF: in vitro fertilization, ICSI: intracytoplasmatic sperm injection. 481 
Figure 2. Average regression lines for vitamin B12 (A) and total homocysteine 482 
(tHcy) (B) concentrations in the total study population. In model 2, a low vitamin B12 483 
(-2 standard deviation (SD), corresponding to 73.4 pmol/l) delays embryonic development 484 
by 1.4 days (95% CI: 1.3-1.4) compared to high concentrations (+2SD, 563.1 pmol/l). 485 
Conversely, high tHcy concentrations (+2SD, 10.4 µol/L) delay embryonic development 486 
by 1.6 days (95% CI: 1.5-1.7) compared to low concentrations (-2SD, 3.0 µmol/l). GA: 487 
gestational age. 488 
  489 
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Table I. Maternal baseline characteristics and biomarkers of I-C metabolism. 490 
 491 
Maternal characteristics 
Total study 
population 
(n=234) 
M 
Excluded 
population 
(n=118) 
M p-value 
Age, y median (range) 32 (22-42) 0 30 (21-44) 0 0.00 
Geographical origin 
Western, n(%) 
Non Western, n(%) 
 
206 (88.0) 
27 (11.5) 
1  
104 (88.1) 
9 (7.6) 
5 0.30 
Educational level 
High, n(%) 
Intermediate, n(%) 
Low, n(%) 
 
135 (57.7) 
93 (39.7) 
5 (2.1) 
1  
65 (55.1) 
45 (38.1) 
3 (2.5) 
5 0.08 
BMI, kg/m
2 
median (range) 
24.2 
(17-42.3) 
1 25.8 
(17.8-45.0) 
2 0.01 
Nulliparous, n(%) 74 (31.8) 1 39 (33.9) 2 0.69 
Alcohol use, n(%) 83 (35.8) 2 38 (34.2) 7 0.78 
Periconception smoking, n(%) 32 (13.7) 1 21 (19.1) 8 0.20 
Periconception folic 
acid/multivitamin use, n(%) 
224 (97.4) 4 108 (93.9) 3 
0.11 
Chronic diseases, n(%) 25 (10.7) 
0 
22 (18.6) 
 0.05 
Vitamin B12 (pmol/l)      
median (range) 
297 (95-953) 0 295.5 
(109-915) 
20 0.76 
RBC folate (nmol/l)        
median (range) 
1408 (541-2811) 12 1294 
(634-1942) 
23 0.01 
tHcy (µmol/l)                   
median (range) 
6.4 (3.7-17.6) 3 6.2 
(3.4-13.6) 
23 0.51 
 492 
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The total study population includes strictly dated pregnancies achieved after spontaneous 
conception (n=138) or IVF/ICSI (n=96). Excluded pregnancies include oocyte(s) donation (n=5), 
missing 3D US scans before 10+2 weeks of gestation (n=7) and spontaneous pregnancies with 
discordant CRL measurements  (≥7 days, n=15), unknown LMP (n=14) or self-reported irregular 
cycle (n=77). Chronic diseases include cardiovascular, autoimmune, endocrine and metabolic 
diseases. The comparison was performed using Chi-square or exact tests for ordinal variables 
and Mann-Whitney U test for continuous variables. M: missing values, BMI: body mass index, 
RBC: red blood cell, tHcy: total homocysteine. 
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Table II. Maternal biomarker effect estimates for the Carnegie stages of 494 
embryonic development derived from linear mixed models. 495 
Biomarkers 
EFFECT ESTIMATES CARNEGIE STAGES 
β (95%CI) 
Model 1 Model 2 
Total study population (n=234) 
Vitamin B12 
RBC folate 
tHcy 
0.001 (0.000; 0.002) * 
0.0004 (0.0001; 0.0007) * 
-0.09 (-0.15; -0.03) ** 
0.001 (0.000; 0.002) * 
0.000 (0.000; 0.001) 
-0.08 (-0.14; -0.02) ** 
Strictly dated spontaneous pregnancies (n=138) 
Vitamin B12 
RBC folate 
tHcy 
0.002 (0.001; 0.003) * 
0.000 (-0.000; 0.001) 
-0.07 (-0.17; 0.03) 
0.002 (0.001; 0.003) * 
0.003 (0.002; 0.004) 
-0.07 (-0.10; 0.02) 
IVF/ICSI pregnancies (n=96) 
Vitamin B12 
RBC folate 
tHcy 
-0.0004 (-0.002; 0.0008) 
0.000 (-0.000; 0.001) 
-0.09 (-0.16; -0.02) ** 
-0.000 (-0.002; 0.001) 
0.001 (0.0005; 0.0015) * 
-0.08 (-0.15; -0.01) * 
 
Effect estimates represent the change in Carnegie stage per unit of increase of 
biomarker concentration. Model 1 shows the crude model with adjustment for 
gestational age. Model 2 includes adjustment for potential confounders (parity, alcohol 
use, smoking habit, folic acid use, age, BMI, chronic diseases, fetal gender).  
RBC: red blood cell, IVF: in vitro fertilization, ICSI: intracytoplasmatic sperm injection, 
tHcy: total homocysteine; CI: confidence interval.  
*p<0.05, **p≤0.01 496 
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FIGURE 2 499 
 500 
 501 
 502 
28 
 
FIGURE 2 503 
 504 
 505 
